Clinical Trials on Relapsed Hematologic Malignancy in Germany

Total 3901 results

Novo Nordisk A/S

Completed

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Safety of NNC 0123-0000-0338 in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

Healthy | Diabetes

Germany
MedImmune LLC

Completed

A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers

Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects

Healthy | Diabetes

Germany
AstraZeneca
Bristol-Myers Squibb

Completed

A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose

Healthy Volunteers

Germany
Profil Institut für Stoffwechselforschung GmbH
Pendragon Medical AG Switzerland

Completed

Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method

Diabetes Mellitus

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation

Tobacco Use Disorder

Germany
West German Center of Diabetes and Health
Bionatural GmbH

Completed

Foot Cream for the Care of Dry and Cracked Skin

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Study of a Non-invasive Glucose Measuring Device

Diabetes Mellitus

Germany
Galderma R&D

Completed

Comparison Dry Foot Skin Between Diabetic and Non-diabetic Subjects and the Effects of Two Cosmetic Foot Care Products

Xerosis Cutis

Germany
Julphar Gulf Pharmaceutical Industries
Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Diabetes Mellitus

Germany
Bayer

Completed

Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone

Hypogonadism

Germany
Novo Nordisk A/S

Completed

Within-subject Variability of Insulin Detemir in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Safety and Tolerability of NN9068 in Healthy Male Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

Healthy | Diabetes

Germany
Julphar Gulf Pharmaceutical Industries
Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

Healthy | Diabetes

Germany
Julphar Gulf Pharmaceutical Industries
Parexel; Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal

Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects

Healthy | Diabetes

Germany
Heidelberg University

Completed

Postoperative Hyperthyroidism

Hyperthyroidism

Germany
Profil Institut für Stoffwechselforschung GmbH
Novo Nordisk A/S

Completed

Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses

Diabetes Mellitus

Germany
University Hospital Muenster

Completed

Safety of Testosterone Undecanoate i.m. in Hypogonadal Men

Hypogonadism

Germany
Klinikum Ludwigshafen
Pfizer

Unknown

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

Age-related Macular Degeneration

Germany
Technische Universität Dresden

Terminated

Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases (RadioCoBRIM)

Brain Metastases | Malignant Melanoma Stage IV | BRAF V600 Mutation

Germany
ARCIM Institute Academic Research in Complementary...

Completed

Resilience Training for Work-related Stress in Employees and the Influence of the Lecture Format on Training Success

Burnout | Work-Related Stress

Germany
PD Dr. Andreas Strauß
Bayer

Recruiting

Osteoporosis and Haemophilia

Osteoporosis | Haemophilia | Bone Mass

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis (EHEC-PEG)

Hemolytic Uremic Syndrome | Hemorrhagic Colitis | Intestinal Infectious Disease | Intestinal Infection Due to E. Coli

Germany
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
Technische Universität Dresden
Celgene Corporation

Terminated

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes (AZALE)

Myelodysplastic Syndromes | Acute Myelogenous Leukemia

Germany
Goethe University

Completed

A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia

Acute Lymphoblastic Leukemia | Leukemia, Myelocytic, Acute | Chronic Myelogenous Leukemia With Crisis of Blast Cells

Germany
University of Cologne

Completed

Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps (STERILE)

CLABSI - Central Line Associated Bloodstream Infection | Catheter-Related Blood Stream Infection

Germany
University Hospital, Bonn

Completed

Directional Spread in Geographic Atrophy (DSGA)

Nonexudative Age-related Macular Degeneration

Germany
Myocardial Solutions

Completed

MyoStrain CMR for the Detection of Cardiotoxicity (Prefect)

Heart Failure | Cardiotoxicity | Chemotherapeutic Toxicity

Germany
IlDong Pharmaceutical Co Ltd

Recruiting

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Type 2 Diabetes

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Characteristics of Empagliflozin Initiators

Type 2 Diabetes

Germany
University Hospital, Bonn

Withdrawn

Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder (DBS-BIPO)

Bipolar Disorder

Germany
Novo Nordisk A/S

Completed

A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

Diabetes

Germany
Sanofi

Completed

A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril

Diabetes Mellitus | Healthy Subjects

Germany
Novo Nordisk A/S

Completed

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects

Healthy | Diabetes

Germany
Becton, Dickinson and Company

Completed

Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

Diabetes

Germany
Sanofi

Completed

LISA-study : Levothyroxin in Nodular Goiter

Goiter, Nodular

Germany
Johannes Gutenberg University Mainz

Completed

Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography

Liver Diseases | Pancreatic Diseases | Pulmonary Disease | Postoperative Respiratory Complications | Malignant Neoplasm of Stomach

Germany

3

Subscribe